Sox9-expressing precursors are the cellular origin of the cruciate ligament of the knee joint and the limb tendons

Genesis

Volumn 48, Issue 11, 2010, Pages 635-644

  Soeda, Tsunemitsu ^a   Deng, Jian Min ^b   De Crombrugghe, Benoit ^b   Behringer, Richard R ^b   Nakamura, Takashi ^a   Akiyama, Haruhiko ^a  

^a KYOTO UNIVERSITY   (Japan)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Cell fate; CreERT2; Cruciate ligament; Limb tendon; Sox9

Indexed keywords

CRE RECOMBINASE; TAMOXIFEN; TRANSCRIPTION FACTOR SOX9;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL FATE; CELL LINEAGE; CREERT2 GENE; DNA MODIFICATION; EMBRYO; EMBRYO DEVELOPMENT; ENZYME ACTIVATION; GENE; GENE LOCUS; GENE TARGETING; GENETIC RECOMBINATION; KNEE CRUCIATE LIGAMENT; LIMB DEVELOPMENT; MESENCHYME; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROGENY; PROTEIN EXPRESSION; SOX9 GENE; STEM CELL; TENDON;

ANIMALS; ANTERIOR CRUCIATE LIGAMENT; CELL DIFFERENTIATION; CELLS, CULTURED; EMBRYO, MAMMALIAN; EXTREMITIES; FEMALE; KNEE JOINT; MICE; MICE, TRANSGENIC; ORGANOGENESIS; POSTERIOR CRUCIATE LIGAMENT; PREGNANCY; SOX9 TRANSCRIPTION FACTOR; STEM CELLS; TENDONS;

MUS;

EID: 78649700651     PISSN: 1526954X     EISSN: 1526968X     Source Type: Journal    
DOI: 10.1002/dvg.20667     Document Type: Article

References (26)

1. Akiyama H, Chaboissier MC, Martin JF, Schedl A, de Crombrugghe B. 2002. The transcription factor Sox9 has essential roles in successive steps of the chondrocyte differentiation pathway and is required for expression of Sox5 and Sox6. Genes Dev 16: 2813-2828.
2. Akiyama H, Kim JE, Nakashima K, Balmes G, Iwai N, Deng JM, Zhang Z, Martin JF, Behringer RR, Nakamura T, de Crombrugghe B. 2005. Osteo-chondroprogenitor cells are derived from Sox9 expressing precursors. Proc Natl Acad Sci USA 102: 14665-14670.
3. Bi W, Deng JM, Zhang Z, Behringer RR, de Crombrugghe B. 1999. Sox9 is required for cartilage formation. Nat Genet 22: 85-89.
4. Bi W, Huang W, Whitworth DJ, Deng JM, Zhang Z, Behringer RR, de Crombrugghe B. 2001. Haploinsufficiency of Sox9 results in defective cartilage primordia and premature skeletal mineralization. Proc Natl Acad Sci USA 98: 6698-6703.
5. Brent AE, Schweitzer R, Tabin CJ. 2003. A somatic compartment of tendon progenitors. Cell 113: 235-248.
6. Chaboissier MC, Kobayashi A, Vidal VI, Lützkendorf S, van de Kant HJ, Wegner M, de Rooij DG, Behringer RR, Schedl A. 2004. Functional analysis of Sox8 and Sox9 during sex determination in the mouse. Development 131: 1891-1901.
7. Chen ZF, Behringer RR. 1995. Twist is required in head mesenchyme for cranial neural tube morphogenesis. Genes Dev 9: 686-699.
8. Danielian PS, Muccino D, Rowitch DH, Michael SK, McMahon AP. 1998. Modification of gene activity in mouse embryos in utero by a tamoxifen-inducible form of Cre recombinase. Curr Biol 8: 1323-1326.
9. Feil R, Brocard J, Mascrez B, LeMeur M, Metzger D, Chambon P. 1996. Ligand activated site-specific recombination in mice. Proc Natl Acad Sci USA 93: 10887-10890.
10. Foster JW, Dominguez-Steglich MA, Guioli S, Kowk G, Weller PA, Stevanovic M, Weissenbach J, Mansour S, Young ID, Goodfellow PN, Goodfellow J, David B, Alan JS. 1994. Campomelic dysplasia and autosomal sex reversal caused by mutations in an SRY-related gene. Nature 372: 525-530.
11. Hogan B, Beddington R, Constantini F, Lacy E. 1994. Manipulating the mouse embryo: A laboratory manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press.
12. Hyde G, Boot-Handford RP, Wallis GA. 2008. Col2a1 lineage tracing reveals that the meniscus of the knee joint has a complex cellular origin. J Anat 213: 531-538.
13. Hyde G, Dover S, Aszodi A, Wallis GA, Boot-Handford RP. 2007. Lineage tracing using matrilin-1 gene expression reveals that articular chondrocytes exist as the joint interzone forms. Dev Biol 304: 825-833.
14. Indra AK, Warot X, Brocard J, Bornert JM, Xiao JH, Chambon P, Metzger D. 1999. Temporally-controlled site-specific mutagenesis in the basal layer of the epidermis: Comparison of the recombinase activity of the tamoxifen-inducible Cre-ER(T) and Cre-ER(T2) recombinases. Nucleic Acids Res 27: 4324-4327.
15. Kobayashi A, Chang H, Chaboissier MC, Schedl A, Behringer RR. 2005. Sox9 in testis determination. Ann N Y Acad Sci 1061: 9-17 (Review).
16. Mori-Akiyama Y, Akiyama H, Rowitch DH, de Crombrugghe B. 2003. Sox9 is required for determination of the chondrogenic cell lineage in the cranial neural crest. Proc Natl Acad Sci USA 100: 9360-9365.
17. Murchison ND, Price BA, Conner DA, Keene DR, Olson EN, Tabin CJ, Schweitzer R. 2007. Regulation of tendon differentiation by scleraxis distinguishes force-transmitting tendons from muscle-anchoring tendons. Development 134: 2697-2708.
18. Nakamura E, Nguyen MT, Mackem S. 2006. Kinetics of tamoxifen-regulated Cre activity in mice using a cartilage-specific CreERT to assay temporal activity windows along the proximodistal limb skeleton. Dev Dyn 235: 2603-2612.
19. Ng LJ, Wheatley S, Muscat GE, Conway-Campbell J, Bowles J, Wright E, Bell DM, Tam PP, Cheah KS, Koopman P. 1997. SOX9 binds DNA, activates transcription, and coexpresses with type II collagen during chondrogenesis in the mouse. Dev Biol 183: 108-121.
20. Ovchinnikov DA, Deng JM, Ogunrinu G, Behringer RR. 2000. Col2a1-directed expression of Cre recombinase in differentiating chondrocytes in transgenic mice. Genesis 26: 145-146.
21. Pryce BA, Watson SS, Murchison ND, Staverosky JA, Dünker N, Schweitzer R. 2009. Recruitment and maintenance of tendon progenitors by TGFbeta signaling are essential for tendon formation. Development 136: 1351-1361.
22. Schweitzer R, Chyung JH, Murtaugh LC, Brent AE, Rosen V, Olson EN, Lassar A, Tabin CJ. 2001. Analysis of the tendon cell fate using Scleraxis, a specific marker for tendons and ligaments. Development 128: 3855-3866.
23. Seymour PA, Freude KK, Tran MN, Mayes EE, Jensen J, Kist R, Scherer G, Sander M. 2007. SOX9 is required for maintenance of the pancreatic progenitor cell pool. Proc Natl Acad Sci USA 104: 1865-1870.
24. Soriano P. 1999. Generalized lacZ expression with the ROSA26 Cre reporter strain. Nat Genet 21: 70-71.
25. Stolt CC, Lommes P, Sock E, Chaboissier MC, Schedl A, Wegner M. 2003. The Sox9 transcription factor determines glial fate choice in the developing spinal cord. Genes Dev 17: 1677-1689.
26. Zou YR, Müller W, Gu H, Rajewsky K. 1994. Cre-loxP mediated gene replacement: A mouse strain producing humanized antibodies. Curr Biol 4: 1099-1103.